Harmonising phenomics information for a better interoperability in the rare disease field.
Document Type
Article
Publication Date
11-2018
Keywords
JGM
JAX Source
Eur J Med Genet 2018 Nov; 61(11):706-714.
ISSN
1878-0849
PMID
29425702
DOI
https://doi.org/10.1016/j.ejmg.2018.01.013
Abstract
HIPBI-RD (Harmonising phenomics information for a better interoperability in the rare disease field) is a three-year project which started in 2016 funded via the E-Rare 3 ERA-NET program. This project builds on three resources largely adopted by the rare disease (RD) community: Orphanet, its ontology ORDO (the Orphanet Rare Disease Ontology), HPO (the Human Phenotype Ontology) as well as PhenoTips software for the capture and sharing of structured phenotypic data for RD patients. Our project is further supported by resources developed by the European Bioinformatics Institute and the Garvan Institute. HIPBI-RD aims to provide the community with an integrated, RD-specific bioinformatics ecosystem that will harmonise the way phenomics information is stored in databases and patient files worldwide, and thereby contribute to interoperability. This ecosystem will consist of a suite of tools and ontologies, optimized to work together, and made available through commonly used software repositories. The project workplan follows three main objectives: The HIPBI-RD ecosystem will contribute to the interpretation of variants identified through exome and full genome sequencing by harmonising the way phenotypic information is collected, thus improving diagnostics and delineation of RD. The ultimate goal of HIPBI-RD is to provide a resource that will contribute to bridging genome-scale biology and a disease-centered view on human pathobiology. Achievements in Year 1.
Recommended Citation
Maiella S,
Olry A,
Hanauer M,
Lanneau V,
Lourghi H,
Donadille B,
Rodwell C,
Köhler S,
Seelow D,
Jupp S,
Parkinson H,
Groza T,
Brudno M,
Robinson P,
Rath A.
Harmonising phenomics information for a better interoperability in the rare disease field. Eur J Med Genet 2018 Nov; 61(11):706-714.